🧬 Tesamorelin (GHRH analog) + Ipamorelin (GHRP) Blend – Research Overview
- Category:
Muscle Growth / Strength, Healing & Recovery, Anti-Aging / Longevity - Primary Research Use:
This blend combines Tesamorelin and Ipamorelin to stimulate natural growth hormone release, supporting muscle growth, fat loss, tissue repair, and anti-aging research. - Simple Analogy:
Think of this blend as a dual signal system: one peptide (Tesamorelin) encourages steady hormone production targeting fat reduction, while the other (Ipamorelin) prompts rapid growth hormone pulses for muscle repair and recovery. - What It Is (Chemical Summary):
Tesamorelin is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog designed to promote growth hormone secretion with a focus on fat metabolism. Ipamorelin is a selective Growth Hormone-Releasing Peptide (GHRP) that triggers growth hormone release with minimal side effects. - Best Suited For:
This blend is commonly researched by scientists focusing on fat loss, muscle hypertrophy, recovery, and metabolic health. - Not Recommended For / Caution In Research With:
Caution is advised when researching subjects with cancer, diabetes, or hormone-sensitive conditions. - Synergistic Peptide Stacks:
- Sermorelin: alternative GHRH analog for comparison (less power)
- BPC 157: for enhanced tissue healing
- TB 500: for anti-inflammatory and recovery support
- Common Dosing Guidelines (Research Use):
| Experience Level | Common Dosage Range (mg) (Tesa / Ipa) |
|---|---|
| Beginner | 0.2–0.5 / 0.2–0.5 |
| Intermediate | 0.5–1.0 / 0.5–1.0 |
| Advanced | 1.0–2.0 / 1.0–2.0 |
- Cycling Information:
Research protocols often involve daily or twice-daily injections over 4 to 12 weeks, with breaks as needed. - Similar Peptides & Comparison Chart:
| Peptide Blend | Mechanism | Duration | Effect Strength | Dosing Frequency | Notable Cautions | Notes |
|---|---|---|---|---|---|---|
| Tes + Ipa | GHRH analog + GHRP | Short (daily) | High | Daily or twice daily | Hormonal effects, cancer caution | Synergistic GH release with fat loss focus |
| Sermorelin | GHRH analog | Short (daily) | Moderate | Daily | Hormonal effects | Alternative GHRH option |
| BPC 157 + TB 500 | Tissue repair & regeneration | Short/medium | High | Daily | Potential tumor growth concerns | Supports healing and recovery |
- Method of Administration:
Typically administered via subcutaneous injection in research settings. - Regulatory Status (FDA Approval):
Both peptides are investigational and not approved by the FDA for medical use. - Legal Disclaimer:
All products discussed are intended for laboratory, scientific, and research purposes only. These products are not approved by the FDA for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease. They must not be used for any form of medical application or personal use.
The information presented is for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before making decisions regarding your health.
By accessing or purchasing these materials, you affirm that you are a qualified researcher or are acting under the supervision of one. All sales are final.
Reviews
There are no reviews yet.